Becker's Healthcare April 24, 2024
Nearly 4 million Medicare patients could be eligible to have Wegovy covered after the FDA approved it to reduce risk of heart attack and strokes, KFF reported April 24.
The FDA approved the drug to reduce the risk of heart attack and strokes in people with cardiovascular disease who are overweight or obese. Currently, Medicare is prohibited by law from covering Wegovy and other medications when used specifically for obesity.
A KFF analysis of Medicare data from 2020 estimated that 3.6 million — or 7% of — beneficiaries had established cardiovascular disease and were obese...
Today's Sponsors
Today's Sponsor